We are live on
!
Find out more
PCM
Poehling Capital Management Portfolio holdings
AUM
$466M
1-Year Est. Return
24.17%
This Fund
S&P 500
This Quarter
Est. Return
+5.4%
1 Year Est. Return
+24.17%
3 Year Est. Return
+70.93%
5 Year Est. Return
+69.6%
10 Year Est. Return
–
AUM
$310M
AUM Growth
+$13.6M
(+4.6%)
Cap. Flow
+$1.63M
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
32.74%
Holding
145
New
10
Increased
32
Reduced
63
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$6.5M |
| 2 |
Organon & Co
OGN
|
+$1.67M |
| 3 |
Fidelity National Information Services
FIS
|
+$1.67M |
| 4 |
Occidental Petroleum
OXY
|
+$1.11M |
| 5 |
Amgen
AMGN
|
+$1.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$2.86M |
| 2 |
Pfizer
PFE
|
+$1.81M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.51M |
| 4 |
Warner Bros
WBD
|
+$1.47M |
| 5 |
Starbucks
SBUX
|
+$1.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 34.86% |
| 2 | Healthcare | 17.42% |
| 3 | Technology | 10.55% |
| 4 | Communication Services | 9.35% |
| 5 | Consumer Discretionary | 6.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Carlyle Group
CG
$17.2B
| $3.65M | 1.18% |
66,446
-1,469
| -2% | -$80K |
|
27
Merck
MRK
$318B
| $3.63M | 1.17% |
47,333
+602
| +1% | +$47.9K |
|
|
28
Amgen
AMGN
$222B
| $3.59M | 1.16% |
15,941
+4,779
| +43% | +$1.01M |
|
|
RTN
29
DELISTED
Raytheon Company
RTN
| $3.5M | 1.13% |
40,680
-1,393
| -3% | -$120K |
|
30
JPMorgan Chase
JPM
$950B
| $3.4M | 1.1% |
21,482
-202
| -0.9% | -$33.2K |
|
31
American International
AIG
$41.3B
| $3.21M | 1.03% |
56,390
+1,875
| +3% | +$107K |
|
32
Altria Group
MO
$114B
| $3.15M | 1.02% |
66,557
-2,779
| -4% | -$127K |
|
33
Blackstone
BX
$110B
| $3.1M | 1% |
23,966
-306
| -1% | -$40.8K |
|
34
GraniteShares Gold Shares
BAR
$1.46B
| $2.97M | 0.96% |
163,530
-46,898
| -22% | -$836K |
|
35
BP
BP
$107B
| $2.84M | 0.92% |
106,747
| – | – |
|
|
BNY
36
Bank of New York Mellon
BNY
$107B
| $2.83M | 0.91% |
48,660
-475
| -1% | -$27.3K |
|
37
Bausch Health
BHC
$2.34B
| $2.75M | 0.89% |
99,775
+704
| +0.7% | +$18.8K |
|
38
Madison Square Garden
MSGS
$9.39B
| $2.75M | 0.89% |
15,854
-289
| -2% | -$52.5K |
|
39
Bank of America
BAC
$442B
| $2.68M | 0.86% |
60,171
-950
| -2% | -$43.3K |
|
40
Affiliated Managers Group
AMG
$9.76B
| $2.66M | 0.86% |
16,160
-121
| -0.7% | -$20.3K |
|
|
41
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$147M
| $2.64M | 0.85% |
8,908
-8,047
| -47% | -$2.86M |
|
42
Johnson & Johnson
JNJ
$625B
| $2.6M | 0.84% |
15,172
-202
| -1% | -$33.1K |
|
|
43
Pfizer
PFE
$153B
| $2.48M | 0.8% |
41,927
-36,604
| -47% | -$1.81M |
|
44
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $2.45M | 0.79% |
87,325
+167
| +0.2% | +$4.82K |
|
45
Goldman Sachs
GS
$303B
| $2.26M | 0.73% |
5,918
-155
| -3% | -$61.4K |
|
46
Bristol-Myers Squibb
BMY
$132B
| $2.24M | 0.72% |
35,947
+6,684
| +23% | +$392K |
|
47
iShares Silver Trust
SLV
$30.9B
| $2.23M | 0.72% |
103,431
-43,093
| -29% | -$931K |
|
|
48
Warner Bros
WBD
$67.1B
| $2.22M | 0.72% |
94,461
-59,198
| -39% | -$1.47M |
|
49
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
$270M
| $2.21M | 0.71% |
82,163
-6,159
| -7% | -$168K |
|
50
Philip Morris
PM
$295B
| $2.2M | 0.71% |
23,178
-1,469
| -6% | -$137K |
|
Similar funds
UC
JHC
HP
ACGA
PC
VCM
SP
LN
Poehling Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Poehling Capital Management held 145 positions worth $310M, up 4.6% from $296M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Poehling Capital Management's Q4 2021 filing shows 10 new, 32 increased, 63 reduced and 6 closed positions. Its largest new stake was Fidelity National Information Services: 14,761 shares worth $1.61M. The largest sale was iPath Series B S&P 500 VIX Short-Term Futures ETN, an estimated $2.86M.
By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Technology.
- Poehling Capital Management's largest Q4 2021 buy was Fidelity National Information Services: 14,761 shares worth $1.61M.
- Poehling Capital Management added most to Paramount Global Class B in Q4 2021, an estimated $6.5M increase.
- Poehling Capital Management's biggest Q4 2021 reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, cutting an estimated $2.86M.
- Poehling Capital Management fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q4 2021, selling an estimated $1.51M.
- Poehling Capital Management's ten largest holdings make up 33% of its $310M portfolio in Q4 2021.
- Poehling Capital Management opened 10 new positions and closed 6 in Q4 2021.
- Poehling Capital Management's portfolio value rose 4.6% quarter-over-quarter to $310M.
Based on Poehling Capital Management's 13F filing for Q4 2021, filed 10 Jan 2022.